Literature DB >> 36036126

Clinical features and molecular epidemiology of carbapenem-resistant Enterobacterales infection in children.

Long Ye1, Li-Yan Zhang, Yue Zhao, Bing Gu, Zhu Wu, Yong-Zheng Peng1,2.   

Abstract

OBJECTIVES: To study the clinical features of children with carbapenem-resistant Enterobacterales (CRE) infection and the molecular characteristics of isolated strains.
METHODS: A retrospective analysis was performed on the clinical data and infection status of the children who were hospitalized in Guangdong Provincial People's Hospital from January 2018 to June 2021. A total of 1 098 non-repetitive strains of Enterobacterales were obtained. Drug sensitivity test, PCR amplification, and resistance-related gene sequencing were performed for 66 isolated CRE strains to observe molecular epidemiology.
RESULTS: Among the 1 098 strains of Enterobacterales, the detection rate of CRE was 6.01% (66/1 098). The 66 CRE strains were isolated from 66 children, among whom there were 37 boys (56%) and 29 girls (44%), with an age of 2 days to 14 years. Among these 66 children, 16 (24%) had an age of <1 month, 28 (42%) had an age of 1-12 months, 11 (17%) had an age of 12-36 months, and 11 (17%) had an age of >36 months. The children with CRE were mainly distributed in the department of neonatology (38 children, 58%) and the pediatric intensive care unit (17 children, 26%). The top three types of specimens with CRE detection were respiratory specimens (48%), midstream urine specimens (21%), and blood specimens (17%). The CRE strains were mainly Klebsiella pneumoniae (45 strains, 68%), Escherichia coli (12 strains, 18%), and Enterobacter cloacae (6 strains, 9%), with high resistance to carbapenems (such as imipenem and ertapenem), penicillin, and cephalosporins, slightly high resistance to commonly used antibiotics, and relatively low resistance to amikacin (14%), levofloxacin (23%), and tobramycin (33%). The carbapenemase genotypes of Klebsiella pneumoniae strains were mainly blaNDM (20 strains, 44%), blaIMP (10 strains, 22%), and blaKPC (5 strains, 11%), and the carbapenemase genotypes of Escherichia coli strains were mainly blaNDM (10 strains, 83%). After sequencing, there were 24 blaNDM-1 strains, 6 blaNDM-5 strains, 5 blaIMP-4 strains, and 3 blaKPC-2 strains, and some genotypes were not identified.
CONCLUSIONS: There is a high incidence rate of CRE infection among children, mainly those aged 1-12 months. CRE generally has high resistance to antibacterial drugs, and metalloenzymes are the main type of carbapenemases for CRE strains in children.

Entities:  

Keywords:  Carbapenem-resistant Enterobacterales; Child; Drug resistance; Molecular epidemiology

Mesh:

Substances:

Year:  2022        PMID: 36036126      PMCID: PMC9425872          DOI: 10.7499/j.issn.1008-8830.2203145

Source DB:  PubMed          Journal:  Zhongguo Dang Dai Er Ke Za Zhi        ISSN: 1008-8830


  17 in total

1.  Comparison of antimicrobial activity between ceftolozane-tazobactam and ceftazidime-avibactam against multidrug-resistant isolates of Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa.

Authors:  Adnan Alatoom; Hashim Elsayed; Karen Lawlor; Laila AbdelWareth; Rania El-Lababidi; Lysettee Cardona; Mohammad Mooty; Maria-Fernanda Bonilla; Ahmad Nusair; Imran Mirza
Journal:  Int J Infect Dis       Date:  2017-06-10       Impact factor: 3.623

2.  Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae.

Authors:  Caroline Dallenne; Anaelle Da Costa; Dominique Decré; Christine Favier; Guillaume Arlet
Journal:  J Antimicrob Chemother       Date:  2010-01-12       Impact factor: 5.790

Review 3.  Metallo-β-lactamases: a last frontier for β-lactams?

Authors:  Giuseppe Cornaglia; Helen Giamarellou; Gian Maria Rossolini
Journal:  Lancet Infect Dis       Date:  2011-05       Impact factor: 25.071

4.  An atomic Boltzmann machine capable of self-adaption.

Authors:  Brian Kiraly; Elze J Knol; Werner M J van Weerdenburg; Hilbert J Kappen; Alexander A Khajetoorians
Journal:  Nat Nanotechnol       Date:  2021-02-01       Impact factor: 39.213

5.  Molecular diversity in mechanisms of carbapenem resistance in paediatric Enterobacteriaceae.

Authors:  Malaika L Little; Xuan Qin; Danielle M Zerr; Scott J Weissman
Journal:  Int J Antimicrob Agents       Date:  2011-11-03       Impact factor: 5.283

6.  The incidence of nosocomial infection in the Intensive Care Unit, Hospital Universiti Kebangsaan Malaysia: ICU-acquired nosocomial infection surveillance program 1998-1999.

Authors:  S W Rozaidi; J Sukro; A Dan
Journal:  Med J Malaysia       Date:  2001-06

Review 7.  Global spread of Carbapenemase-producing Enterobacteriaceae.

Authors:  Patrice Nordmann; Thierry Naas; Laurent Poirel
Journal:  Emerg Infect Dis       Date:  2011-10       Impact factor: 6.883

Review 8.  Structure, Genetics and Worldwide Spread of New Delhi Metallo-β-lactamase (NDM): a threat to public health.

Authors:  Asad U Khan; Lubna Maryam; Raffaele Zarrilli
Journal:  BMC Microbiol       Date:  2017-04-27       Impact factor: 3.605

9.  Carbapenem-resistant Enterobacterales colonization and subsequent infection in a neonatal intensive care unit in Shanghai, China.

Authors:  L Yin; L He; J Miao; W Yang; X Wang; J Ma; N Wu; Y Cao; C Wang
Journal:  Infect Prev Pract       Date:  2021-05-12

Review 10.  New strategies and structural considerations in development of therapeutics for carbapenem-resistant Enterobacteriaceae.

Authors:  Thea Brennan-Krohn; Roman Manetsch; George A O'Doherty; James E Kirby
Journal:  Transl Res       Date:  2020-03-02       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.